Tenecteplase contraindications: Difference between revisions

Revision as of 20:01, 21 July 2014

Redirect to:

@@ Line 1: / Line 1: @@
-__NOTOC__
+#REDIRECT [[Tenecteplase#Contraindications]]
-{{Tenecteplase}}
-{{CMG}}; {{AE}} {{SS}}
-==Contraindications==
+[[Category: Cardiovascular Drugs]]
-TNKase therapy in patients with acute myocardial infarction is contraindicated in the following situations because of an increased risk of bleeding (seeWARNINGS):
+[[Category: Drug]]
-*Active internal bleeding
-*History of cerebrovascular accident
-*Intracranial or intraspinal surgery or trauma within 2 months
-*Intracranial neoplasm, [[arteriovenous malformation]], or [[aneurysm]]
-*Known bleeding diathesis
-*Severe uncontrolled [[hypertension]]<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TNKASE (TENECTEPLASE) KIT [GENENTECH, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69e391bf-1250-4083-aa60-6aa41c33657f | publisher =  | date =  | accessdate = 6 February 2014 }}</ref>
-==References==
-{{Reflist|2}}
-[[Category:Thrombolytic drugs]]
-[[Category:Cardiovascular Drugs]]
-[[Category:Drugs]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}